|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
152,980,000 |
Market
Cap: |
2.50(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$12.12 - $22.17 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Certara is a holding company. Through its subsidiaries, Co. delivers software products and technology-enabled services to customers to realize the benefits of biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions and market access. Co.'s End-to-End Platform provides software and technology-enabled services. Co. deploys its software to customers on public and private cloud networks, on-premises, and in data centers. Co.'s technology-enabled, biosimulation services help customers who do not have staff capability or availability to gain the benefits of biosimulation. Co. also provides related, technology-enabled services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
50,000 |
Total Buy Value |
$0 |
$0 |
$79,058 |
$821,458 |
Total People Bought |
0 |
0 |
1 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
4 |
Total Shares Sold |
25,427 |
37,427 |
107,755 |
38,359,838 |
Total Sell Value |
$442,001 |
$658,001 |
$1,817,562 |
$597,865,261 |
Total People Sold |
2 |
2 |
3 |
6 |
Total Sell Transactions |
4 |
6 |
8 |
23 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Slaine Mason P |
|
|
2022-11-14 |
4 |
S |
$15.27 |
$64,241 |
D/D |
(4,207) |
906,115 |
|
-63% |
|
Walsh Matthew M |
|
|
2022-11-14 |
4 |
S |
$14.74 |
$177,750 |
D/D |
(12,059) |
167,901 |
|
-63% |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2022-11-09 |
4 |
AS |
$13.48 |
$32,177 |
D/D |
(2,387) |
74,859 |
|
68% |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2022-11-01 |
4 |
D |
$12.23 |
$15,214 |
D/D |
(1,244) |
77,246 |
|
- |
|
Virkler Drayton |
INTERIM PRESIDENT, REG & ACCES |
|
2022-09-30 |
4 |
D |
$13.31 |
$53,293 |
D/D |
(4,004) |
9,591 |
|
- |
|
Virkler Drayton |
INTERIM PRESIDENT, REG & ACCES |
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,595 |
13,595 |
|
- |
|
Mclean Stephen M. |
|
|
2022-08-19 |
4 |
B |
$16.32 |
$326,400 |
D/D |
20,000 |
42,000 |
0.01 |
-3% |
|
Schemick Michael Andrew |
CHIEF FINANCIAL OFFICER |
|
2022-08-17 |
4 |
B |
$16.64 |
$416,000 |
D/D |
25,000 |
517,870 |
0.01 |
-1% |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2022-08-16 |
4 |
AS |
$17.71 |
$177,100 |
D/D |
(10,000) |
78,490 |
|
-10% |
|
Eqt Fund Management S.a R.l. |
10% Owner |
|
2022-08-16 |
4 |
S |
$17.38 |
$104,356,785 |
I/I |
(6,004,418) |
29,954,521 |
|
10% |
|
Slaine Mason P |
Director |
|
2022-08-16 |
4 |
S |
$17.38 |
$3,171,416 |
D/D |
(182,475) |
910,322 |
|
10% |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2022-08-01 |
4 |
D |
$22.99 |
$64,648 |
D/D |
(2,812) |
12,808 |
|
- |
|
Aspbury Robert |
PRESIDENT, SIMCYP |
|
2022-07-01 |
4 |
D |
$21.46 |
$18,971 |
D/D |
(884) |
275,215 |
|
- |
|
Slaine Mason P |
|
|
2022-06-02 |
4 |
S |
$19.52 |
$4,890,000 |
D/D |
(250,000) |
1,092,797 |
|
39% |
|
Eqt Fund Management S.a R.l. |
10% Owner |
|
2022-05-31 |
4 |
S |
$19.00 |
$28,500,000 |
I/I |
(1,500,000) |
35,958,939 |
|
38% |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2022-04-04 |
4 |
AS |
$22.29 |
$74,716 |
D/D |
(3,352) |
98,490 |
|
-21% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2022-04-01 |
4 |
D |
$21.48 |
$37,010 |
D/D |
(1,723) |
209,564 |
|
- |
|
Schemick Michael Andrew |
CHIEF FINANCIAL OFFICER |
|
2022-04-01 |
4 |
D |
$21.48 |
$85,340 |
D/D |
(3,973) |
492,870 |
|
- |
|
Edge Justin |
PRES., REGULATORY & ACCESS |
|
2022-04-01 |
4 |
D |
$21.48 |
$49,962 |
D/D |
(2,326) |
394,764 |
|
- |
|
Pedersen Leif E |
PRESIDENT, SOFTWARE |
|
2022-04-01 |
4 |
D |
$21.48 |
$42,573 |
D/D |
(1,982) |
226,723 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2022-04-01 |
4 |
D |
$21.48 |
$198,797 |
D/D |
(9,255) |
2,168,796 |
|
- |
|
Choe Jieun W. |
CHIEF STRATEGY & MARKETING |
|
2022-04-01 |
4 |
D |
$21.48 |
$41,113 |
D/D |
(1,914) |
248,577 |
|
- |
|
Aspbury Robert |
PRESIDENT, SIMCYP |
|
2022-04-01 |
4 |
D |
$21.48 |
$61,648 |
D/D |
(2,870) |
276,099 |
|
- |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2022-04-01 |
4 |
D |
$21.48 |
$32,907 |
D/D |
(1,532) |
101,842 |
|
- |
|
Slaine Mason P |
|
|
2022-03-17 |
4 |
S |
$20.25 |
$2,531,250 |
D/D |
(125,000) |
1,342,797 |
|
-10% |
|
187 Records found
|
|
Page 3 of 8 |
|
|